Cita APA (7a ed.)

Moens, S., Zhao, P., Baietti, M. F., Marinelli, O., Haver, D. V., Impens, F., . . . Amant, F. (2021). The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers. Nature Portfolio.

Cita Chicago Style (17a ed.)

Moens, Stijn, et al. The Mitotic Checkpoint Is a Targetable Vulnerability of Carboplatin-resistant Triple Negative Breast Cancers. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Moens, Stijn, et al. The Mitotic Checkpoint Is a Targetable Vulnerability of Carboplatin-resistant Triple Negative Breast Cancers. Nature Portfolio, 2021.